New York took a step toward improving access to services for residents with traumatic brain injuries with a bill signed into ...

A care and treatment service in West Bromwich have retained their ‘outstanding’ rating across all six domains in a recent ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Common Brain Network Detected Among Veterans With Traumatic Brain Injury Could Protect Against ... This opens up new avenues for the treatment of a range of neurological and ...

Two involuntary secure-care sites are due to open in spring for people struggling with severe addiction, brain injury and ...

This undated photo provided by Alicia Arritt, shows her with former Army Special Forces soldier Matthew Livelsberger, who ...

For people diagnosed with Parkinson’s Disease, staying active can be difficult without help. In January 2021, Christine ...

Cirtuvivint is under clinical development by Biosplice Therapeutics and currently in Phase I for Refractory Acute Myeloid Leukemia.

Benzgalantamine DR is under clinical development by AlphaCognition and currently in Phase I for Traumatic Brain Injury.

CervoMed Inc.’s stock cratered early Tuesday after the biotech company said a midstage trial of a treatment for patients with dementia with Lewy bodies, or DLB, failed to meet its main goals.